Company Overview and News

 
Commentary: A booming real estate market in the Philippines reveals its diaspora's purchasing power

2018-09-16 channelnewsasia
Overseas Filipinos have become purveyors of a new ultra-modern lifestyle that is rapidly being introduced to every corner of the Philippines, says one observer.
FVSMF AYAAY FLI ALI AYAAF

 
Filinvest expanding residential, office projects in Mimosa

2018-08-27 bworldonline
FILINVEST Land, Inc. (FLI) is expanding its residential and office projects in Pampanga with its redevelopment of the 201-hectare Mimosa+ Leisure City.
FVSMF FLI

 
FLI on track to complete 2nd office tower in Pampanga

2018-08-23 bworldonline
CLARK, PAMPANGA — Filinvest Land, Inc. (FLI) is set to finish its second office tower within the group’s 201-hectare tourism and leisure estate in Pampanga this year, as it seeks to cater to the business process outsourcing (BPO) firms flocking to the province.
FVSMF FLI

 
Filinvest to finish second office tower in Pampanga by December

2018-08-23 bworldonline
Clark, Pampanga—Filinvest Land, Inc. (FLI) is set to finish its second office tower within its 201-hectare tourism and leisure estate in Pampanga this year, as it seeks to cater to the influx of business process outsourcing (BPO) firms in the province.
FVSMF FLI

 
FDC 7B H1 net income up 45%

2018-08-17 business.inquirer.net
The Gotianun family-led Filinvest Development Corporation (FDC) reported first half net income of Php7.2B, a 45% increase vs. the same period in 2018. Majority of revenues, or 44%, were contributed by the property business – which includes both the real estate and hotel groups. Banking (38%), power (11%) and sugar (6%) contributed the balance.
FILIY FVSMF FDC FLI

5
Filinvest net income rises 27%

2018-05-16 bworldonline
FILINVEST Development Corp. (FDC) delivered a 27% increase in its net income attributable to the parent for the first quarter of 2018, driven mainly by its property unit and investments in the hospitality and leisure sector.
FILIY FVSMF FDC FLI

5
FDC nets P2.8B

2018-05-16 business.inquirer.net
Gotianun-led conglomerate Filinvest Development Corp. grew first quarter net profit by 18 percent year-on-year to P2.8 billion, mostly driven by its property business.
FILIY FVSMF FDC FLI

8
Widus sees $1-billion expansion in Clark

2018-05-07 bworldonline
KOREAN-LED Widus International Leisure, Inc., the operator of the Marriot hotel chain in Clark, Pampanga, is looking at expanding its hotel projects in the city to total to $1 billion in the next few years.
FILIY FVSMF MWP FDC GMRINFRA GMQRY FLI MWIDE 532754

5
Filinvest Land keeps capex steady in 2018

2018-04-22 bworldonline
FILINVEST LAND, Inc. (FLI) is keeping its capital spending steady in 2018, as the Gotianun-led developer aims for at least high single-digit growth boosted by its office segment.
FILIY FVSMF FDC FLI

6
Filinvest Development nets P10.3 billion

2018-04-10 bworldonline - 1
FILINVEST Development Corp. (FDC) grew its net profit by more than a fifth last year, buoyed by its banking and property businesses.
FILIY FVSMF EW FDC FLI

4
FDC nets P10.3B

2018-04-10 business.inquirer.net
Gotianun-led Filinvest Development Corp. (FDC) boosted net profit last year by 21 percent to P10.3 billion, driven by higher earnings from the banking, property and power generation businesses.
FVSMF FLI

5
Gotianun-led FDC to build $200-M casino in Clark

2018-04-05 bworldonline
THE GOTIANUN FAMILY is the latest group to venture into the booming gaming sector after securing a license to build a casino in Pampanga.
FILIY FVSMF FDC FLI

4
Filinvest breaks ground on San Pedro project

2018-03-23 bworldonline
LISTED company Filinvest Land, Inc. recently broke ground on its a mid-income residential project called Southwind, the newest addition to it’s South Peak community development in San Pedro, Laguna.
FVSMF FLI

5
Rental revenues push FLI profit 9% higher in 2017

2018-03-21 bworldonline - 1
FILINVEST Land, Inc. (FLI) grew its earnings by 9% in 2017, fueled by the expansion of its rental business alongside demand for both retail and office spaces.
FVSMF FLI

4
Filinvest Land grows earnings by 9% in 2017

2018-03-21 bworldonline
Filinvest Land, Inc. (FLI) grew its earnings by 9% in 2017, fueled by the expansion of its rental properties alongside demand from both retail and office spaces.
FVSMF FLI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: Y24916101